Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$14.52 - $22.46 $180,251 - $278,818
-12,414 Closed
0 $0
Q1 2021

Sep 21, 2023

BUY
$16.57 - $21.08 $205,699 - $261,687
12,414 New
12,414 $253,000
Q1 2021

May 14, 2021

BUY
$16.57 - $21.08 $205,699 - $261,687
12,414 New
12,414 $253,000
Q3 2019

Nov 13, 2019

SELL
$16.51 - $23.78 $5.07 Million - $7.31 Million
-307,300 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$15.6 - $25.15 $3.37 Million - $5.43 Million
215,731 Added 235.59%
307,300 $5.02 Million
Q1 2019

May 15, 2019

BUY
$22.57 - $28.15 $2.07 Million - $2.58 Million
91,569 New
91,569 $2.08 Million

Others Institutions Holding TBPH

About Theravance Biopharma, Inc.


  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $622M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.